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Transgenic banana has been developed to prevent hepatitis B through vaccination. Its production 
seems to be an ideal alternative for cheaper vaccines.  The objective of this paper is to assess the 
ethical perception of transgenic banana which involved the transfer of human albumin gene, and to 
compare their ethical dimensions across several demographic variables. A survey was carried out in 
the Klang Valley region from August, 2009 till February, 2010 using self constructed multi-dimensional 
instrument measuring ethical perception of transgenic banana. The respondents (n=434) were stratified 
according to stakeholder groups which consisted of eleven groups: Producers, scientists, policy 
makers, non-governmental organisations (NGOs), media, religious scholars (Islamic, Buddhist, 
Christian, and Hindu scholars), university students and consumers. Results of the study showed that 
the Malaysian stakeholders were unfamiliar with transgenic banana, and perceived transgenic banana 
as having moderate risks and marginally beneficial to the Malaysian society and the ethical aspects 
were moderately acceptable to them as well as from their religous point of view. ANOVAs showed that 
all the four ethical dimensions: Familiarity, denying benefits, ethical acceptance and perceived risks 
significantly differed across stakeholders’ groups while the last three dimensions also differed 
significantly across religion.  Perceived risks, denying benefits, ethical and religious acceptance further 
differed significantly across races. However, with respect to ages, only the factor familiarity differed 
and no significant difference were found across educational level and gender. Although, the idea of 
producing an edible vaccine through transgenic banana seems to be an ideal alternative for cheaper 
vaccines, the Malaysian stakeholders were still not ready and have a cautious stance. The research 
finding is useful to understand the social construct of the ethical acceptance of cross-species gene 
transfers in developing country. Further research needs to be done to determine the perspectives of 
various religions on the use of human gene in plants. 
 





Nowadays, with the development of genetic engineering, 
plants characteristics can be modified for the develop-
ment of pharmaceutical products. Through genetic 
engineering, an edible vaccine can be develop as an 
alternative for cheaper vaccines compared to the typical 
vaccine that are more expensive due to the storage, 
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Thomas, 2004). Typical vaccines are composed of killed 
or attenuated disease-causing organisms (Mishra et al., 
2008) while transgenic pharmaceutical plants are 
modified by the introduction of novel gene sequences 
which drive the production of proteins or peptides that 
have properties allowing them to be used as precursors 
in the synthesis of medical compounds (Goldstein and 
Thomas, 2004). 
An edible vaccines has many advantages identified 
such as edible means of administration, reduced need for 
medical personnel and sterile injection conditions, econo-





protein are free of pathogens and toxins, storage near the 
site of use, heat-stable, eliminating the need for refrige-
ration, antigen protection through bio-encapsulation, 
subunit vaccine (not attenuated pathogens) means 
improve safety, seroconversion in the presence of 
mucosal immunity, enhanced compliance (specially in 
children), delivery of multiple antigens, integration with 
other vaccine approaches, plant derived antigens assem-
ble spontaneously into oligomers and onto virus like 
particles (Mei et al., 2006).  But there is still limitations in 
producing edible vaccines such as the development of 
immunotolerance of vaccine peptide or protein, consis-
tency of dosage form fruit to fruit, plant-plant and 
generation-generation is not similar, stability of the 
vaccine in fruit is not known, evaluation of the dosage 
requirement is tedious, selection of the best plant is 
difficult, certain foods are not eaten raw, and cooking the 
food might weaken the medicine present in it (Mei et al., 
2006). However, Kong et al. (2001) claimed that they 
could substantially reduced the immunogenicity of the 
vaccine by cooking (boiling) the food. They also found 
that the plant-derived HBsAg which is delivered as food is 
orally immunogenic in mice and elicit a primary antibody 
response.  Furthermore, the strong secondary response 
also seen after boosting with rHBsAg represents a true 
memory response generated from the mice fed by HBsAg 
transgenic potatoes. 
Hepatitis B is a major global health problem and the 
most serious type of viral hepatitis spreads through blood 
transfusion and sexual contact.  It is a viral infection that 
attacks the liver and can cause both acute and chronic 
disease. It is estimated that two billion people are 
infected with hepatitis B virus (HBV), and more than 350 
million have chronic (long-term) liver infections in the 
worldwide(http://www.who.int/mediacentre/factsheets/fs2
04/en/). Therefore, the production of edible vaccine for 
hepatitis B through the development of transgenic plants 
could be an alternative for cheaper vaccine. 
Arntzen has developed transgenic banana for the 
delivery of edible vaccine in developing countries 
(Prakash, 1996).  Banana was considered as an ideal 
fruit for the production of edible vaccine because of 
several factors, such as those that easily grows in the 
tropics (Prakash, 1996) and subtropics (Sunil Kumar et 
al., 2004), favourite food for small children (Prakash, 
1996), digestibility and palatability by the infants (Sunil 
Kumar et al., 2004) and can be consumed uncooked, 
thus, eliminating the possibility of protein denaturation 
due to high temperature (Goldstein and Thomas, 2004). 
Since genetic engineering is new and the advancement 
in these areas have been so rapid, it has been the object 
of some doubts, fears, concerns, as well as an intense 
and divisive debate worldwide on the potential risks to 
human health, to the environment and to the society 
(Costa-Font and Gil, 2009). The debate was typically 
seen as a conflict between supporters who envisage the 
potential benefits  and  the  opposition  groups  who  view  




GM products as tampering with nature (Bloomfield, 
2011). Although the benefits of transgenic banana was 
promising, past studies also showed that genetic engi-
neering has been associated with negative constructs, 
such as ethical concerns, changing nature, and its 
possible risks to the environment (Blaine et al., 2002). 
According to Batalion (2000), the central problem 
underlying the use of biotechnology is not just its short-
term benefits and long term drawbacks, but the overall 
attempt to “control” living nature on an erroneous 
mechanistic view. Humans generally have conscience 
and religious beliefs and many of these religious beliefs 
do not allow unrestricted interference with life, such as, 
genetic engineering (Epstein, 1998). The pace of dis-
covery in genetic-based biotechnology is very rapid and 
there is anxiety that a kind of technological compulsion (‘if 
we can do it, let’s do it’) have been driving developments 
ahead of proper ethical consideration of their propriety 
(Polkinghorne, 2000). Furedi (1997) argued that societal 
and individual risk perceptions are proportional to a 
system of moral values. Individuals were willing to accept 
some level of risk if a product was deemed worthy and 
was not morally objectionable. Of the variables studied, 
namely, usefulness, perceived risk and morality, it was 
found that moral acceptability was the strongest predictor 
of support for biotechnology by the Canadians (Eisendel, 
2000). Gaskell et al. (2000) also noticed that moral 
acceptability appeared to act as a veto for the support of 
biotechnology among the Europeans. The results of the 
US public survey (Priest, 2000) also suggested the possi-
bility of the US people using moral reasoning in forming 
opinions towards six applications of biotechnology. 
Basic categories of moral or ethical concerns regarding 
modern biotechnology fall into two classes: intrinsic and 
extrinsic (Comstock, 2000).  Extrinsic objection refers to 
the concerns regarding the possible concerns and risks 
of different application of biotechnology to human health, 
environment, economy and society (Gott and Monamy, 
2004). While, intrinsic objections hold that, the process of 
modern biotechnology is objectionable in itself. This belief 
is associated with the claim that the technology is not 
natural. This technology is perceived as changing nature 
and is attempting to play “God”. Beyond this, other 
researchers have raised intrinsic issues which include 
biotechnology being perceived as a threat to the natural 
order of living things (BABAS, 1999) and whether human 
has the rights to modify living things for their benefits 
(Brook 2003). These intrinsic concerns include a religious 
dimension and concern on the underlying set of religious 
beliefs and principles concerning the relationships 
between God, nature and human beings (BABAS, 1999). 
Modern biotechnology has been given priority by the 
Malaysian government to spearhead the country’s 
economy. The future development and commercialization 
of modern biotechnology products in Malaysia depends 
heavily on public acceptance. Besides, main decision on 
agriculture activities are shown  to  be  influenced  by  the  




Table 1. Background of respondents surveyed. 
 
Background Frequency Percentage 
Stakeholders’ group 
Producers 25 5.8 
Scientists 32 7.4 
Policy Maker 39 9.0 
NGOs 26 6.0 
Media 29 6.7 
University students     44 10.1 
Islamic scholars 43 9.9 
Buddhist scholars 32 7.4 
Christian scholars 34 7.8 
Hindu scholars 34 7.8 
Consumers 96 22.1 
 
Gender 
Male 165 38.0 
Female 269 62.0 
 
Educational level 
Secondary 59 13.6 
Diploma/pre-U 102 23.5 
University 273 62.9 
 
Age 
18 - 25 years 201 46.3 
26 - 40 years 156 35.9 
≥ 41 years 77 17.7 
 
Race 
Malay 259 59.7 
Chinese 78 18.0 
Indian 72 16.6 
Sabah natives 11 2.5 
Sarawak natives 9 2.1 
Others 5 1.2 
 
Religion 
Islam 264 60.8 
Buddha 52 12.0 
Hindu 60 13.8 
Christian 52 12.0 




public (Ogunsumi, 2007). This paper will look at the 
Malaysians views on transgenic banana. Malaysians has 
been found to be concerned about the moral aspects of 
several modern biotechnology applications such as 
genetically modified food and medicine (ISAAA-UIUC, 
2003; Latifah et al., 2008, 2010). Past study has indicated 
that moral concern was found to be an important 





Valley (Latifah et al., 2010). The objective of this paper is 
to assess the ethical perception of transgenic banana 
(containing human albumin gene) held by Malaysian 
stakeholders and to compare their perception across 
several demographic variables. 
 
 
MATERIALS AND METHODS 
 
The research data was collected by means of a face to face survey 
of adults (age: 18 years old and above), residing in the Klang Valley 
region. A total of 434 respondents completed questionnaires from 
August, 2009 till February, 2010.  The respondents were stratified 
according to stakeholders’ groups which consisted of eleven 
groups: producers, scientists, policy makers, NGOs, media, 
religious scholars (Islamic scholars, Buddhist scholars, Christian 
scholars, and Hindu scholars), university students and consumers 
(Table 1). Thirty eight percent (38%) of the respondents were male, 
62% were female, with age ranging from 17 to 64 years old, 13.6% 
of the respondents had at least secondary level of educations, 
23.5% had pre-university education or diploma holders while the 
remaining 62.9% had tertiary level of education. 
The survey was conducted with the assistant of trained enume-
rators. A basic concept, pros and cons of modern biotechnology 
were first introduced before the respondents were asked to 
complete the questionnaires. Further explanation was also given 
when enquired. The multi-dimensional instrument to measure 
ethical aspects of transgenic banana used in this study was 
constructed based on the work of earlier researches (Latifah et al., 
2007, Gaskell et al., 2000; Macer, 2000; Rohrmann, 1999; Kirk et 
al., 2002). All items were measured on 7 point Likert scales. These 
scales provided a reliable measure for the ethical aspects of 
transgenic banana. The principal component factor analyses using 
varimax rotation yielded five dimensions: Familiarity, perceived 
risks, denying benefits if it is not developed, religious and ethical 
acceptance. These dimensions were used to identify the Malaysian 
stakeholders’ perception towards ethical aspects of transgenic 
banana. 
The SPSS 14.0 software was used for data analysis. T-test was 
carried out to compare the differences in ethical perception across 
gender while comparison across age groups, educational level, 
religion, race and stakeholders groups were determined by analysis 
of variance (ANOVA). However, ANOVAs were only carried out 
across categories which have the minimum required number of 
respondents to achieve a medium effect size (f = 0.25) at P = 0.05, 
to obtain a power of 0.80 (Cohen, 1969). For race, the minimum 
required number of samples per category is 52; thus, comparisons 
were made only across the three major races. As for religion, the 
minimum required number of sample per category was 44; this 
means that comparisons were carried out only across the three 
major religions. For all other background variables, each category 





Perception across stakeholders’ groups 
 
Overall, the Malaysian stakeholders were not very 
familiar with transgenic banana with a mean score of 3.22 
which is below the mid-point value of 4.0. They perceived 
transgenic banana as having moderate risks (mean score 
of 4.22) and were not very acknowledging of the potential 
benefits of transgenic banana to the society (mean score 
of 3.97; about the mid-point value of 4.0). However, the




Table 2. Familiarity and perceived risks of transgenic banana across stakeholders’ groups. 
  
Stakeholders’ group 
Familiarity Perceived risk 






Producers 3.20  ±  1.08 Moderate 4.04  ± 1.39 Moderate 
Scientists 3.95  ±  1.39 Moderate 4.48  ± 1.06 Moderate 
Policy makers 3.04  ±  1.33 Moderate 4.11  ± 1.38 Moderate 
NGOs 3.32  ±  1.18 Moderate 4.21  ± 1.20 Moderate 
Media 3.69  ±  1.11 Moderate 3.77  ± 1.28 Moderate 
University students 3.16  ±  1.05 Moderate 4.37  ± 1.19 Moderate 
Islamic scholars 2.62  ±  1.38 Low 4.88  ± 1.45 Moderate 
Buddhist scholars 3.32  ±  1.00 Moderate 3.81  ± 1.13 Moderate 
Christian scholars 2.85  ±  1.18 Low 4.80  ± 1.23 Moderate 
Hindu scholars 2.77  ±  1.09 Low 3.65  ± 1.05 Moderate 
Consumers 3.42  ±  0.98 Moderate 4.12  ± 1.30 Moderate 
Overall 3.22  ±  1.19 Moderate 4.22  ± 1.30 Moderate 
 




Table 3. One way ANOVA to compare ethical perception of 
transgenic banana across stakeholders’ groups. 
 
Variable F-value Significant 
Familiarity 4.23 0.000*** 
Perceived risks 3.65 0.000*** 
Denying benefits 3.75 0.003** 
Religious acceptance 1.69 0.080 
Ethical acceptance  3.51 0.000*** 
 




ethical aspects were moderately acceptable (mean score 
of 4.37) to them as well as from their religous point of 
view (mean score 4.50). 
Almost all stakeholders’ groups were classified as not 
very familiar with transgenic banana (mean score value 
below the mid-point value, 4.0) including the scientists 
and policy makers (Table 2). Religious scholars except 
the Buddhist scholars were found to have low level of 
familiarity of transgenic banana (Table 2). ANOVA 
showed significant difference for familiarity across 
stakeholders’ groups (F = 4.23, p < 0.001) (Table 3). Post 
hoc tests confirmed that the Scientists were more familiar 
with transgenic banana compared to the Muslim, 
Christian and Hindu religious scholars. The media and 
consumers also have higher familiarity level of transgenic 
banana compared to the Muslim scholars. 
Table 2 also shows that three groups of Klang Valley 
stakeholders (media, Buddhist and Hindu scholars) 
perceived less risk (mean score below the mid-point 
value, 4.0) of transgenic banana compared to the remain-
ing eight stakeholders groups who rated transgenic 
banana as risky (mean score above the mid-point value, 
4.0). ANOVA showed significant difference for perceived 
risks across stakeholders’ groups (F = 3.65, p < 0.001) 
(Table 3) but post-hoc tests could not detect any 
significant differences across the groups. Producers, 
Scientists, Policy makers, Media and Consumers consi-
dered that the benefits of transgenic banana will be 
denied if it is not developed (mean score above mid-point 
value of 4.0) while the NGOs, university students and 
religious scholars (except the Hindu scholars) perceived 
it as less beneficial to society (mean score below mid-
point value of 4.0) (Table 4). ANOVAs were significant for 
the factor denying benefits of transgenic banana across 
stakeholders’ groups (F = 3.75, p < 0.01) (Table 3). Post-
hoc test confirmed that the Scientists perceived higher 
benefits compared to the Christian scholars. With respect 
to religious view, the Islamic scholars were found to 
accept less of transgenic banana compared to other 
stakeholders’ groups (Table 3). ANOVA were not signifi-
cant for religious acceptance of transgenic banana 
across stakeholders’ groups (Table 3). 
Majority of the stakeholders’ groups claimed that trans-
genic banana was acceptable ethically and from their 
religious perspectives (mean score above the mid-point 
value of 4.0) (Tables 4 and 5). Only the  Muslim  scholars  








Familiarity Perceived risk 






Producers 4.27 ± 1.43 Moderate 4.18  ±  1.63 Moderate 
Scientists 4.51 ± 1.31 Moderate 4.63  ±  1.53 Moderate 
Policy makers 4.11 ± 1.40 Moderate 4.38  ±  1.95 Moderate 
NGOs 3.85 ± 1.34 Moderate 4.08  ±  1.48 Moderate 
Media 4.17 ± 1.03 Moderate 4.12  ±  1.85 Moderate 
University students 3.89 ± 1.12 Moderate 4.52  ±  1.88 Moderate 
Islamic scholars 3.53 ± 1.66 Moderate 3.53  ±  2.00 Moderate 
Buddhist scholars 3.98 ± 0.88 Moderate 4.70  ±  1.40 Moderate 
Christian scholars 3.23 ±1.36 Moderate 4.66  ±  1.65 Moderate 
Hindu scholars 4.25 ± 1.31 Moderate 4.63  ±  1.26 Moderate 
Consumers 4.00 ± 1.12 Moderate 4.46  ±  1.56 Moderate 
Overall 3.97 ± 1.30 Moderate 4.37  ±  1.69 Moderate 
 








Mean score ± standard deviation Interpretation 
Producers 4.25  ±  1.67 Moderate 
Scientists 5.00  ±  1.25 Moderate 
Policy makers 4.25  ±  1.59 Moderate 
NGOs 4.12  ± 1.56 Moderate 
Media 4.75  ±  1.57 Moderate 
University students 4.38  ±  1.46 Moderate 
Islamic scholars 3.83  ±  1.46 Moderate 
Buddhist scholars 4.94  ±  1.23 Moderate 
Christian scholars 4.10  ±  1.38 Moderate 
Hindu scholars 5.28  ±  1.21 High 
Consumers 4.62  ±  1.36 Moderate 
Overall 4.50  ±  1.47 Moderate 
 




were hesitant in their ethical acceptance of transgenic 
banana as well as acceptance from their religious view 
(mean score below the mid-point value of 4.0). On the 
other hand, the Hindu scholars regarded the ethical 
aspects of transgenic banana as highly acceptable. 
There is a significant difference in ethical acceptance 
across stakeholders’ groups (F = 3.51, p < 0.001) (Table 
3). Post-hoc test showed significant different in the ethical 




Perception across races 
 
All respondents irrespective of races were not very fami- 
liar with transgenic banana (mean score below the mid-
point value of 4.0) but were moderately accepting of the 
ethical aspects of transgenic banana as well as accep-
tance from their religious views (Table 6). The Malays 
and Chinese perceived transgenic banana as risky to 
human and environment (mean score above mid-point 
value of 4.0) and not beneficial to society (mean score 
below mid-point value of 4.0) (Table 6). On the other 
hand, the Indian respondents rated transgenic banana as 
less risky to the human and environment (mean score 
below mid-point value of 4.0) and believed that the 
potential benefits of transgenic banana will be denied if it 
is not developed (mean score above mid-point value of 
4.0) (Table  6).  ANOVA  were  significant  for  the  factor 




Table 6. Ethical perception of transgenic banana across races. 
 
Variable Mean score ± standard deviation Interpretation 
Familiarity   
Malay 3.27  ± 1.20 Moderate 
Chinese 3.35  ± 1.11 Moderate 
India 2.85  ± 1.19 Low 
 
Perceived risk 
Malay 4.23  ± 1.27 Moderate 
Chinese 4.19  ± 1.29 Moderate 
India 3.94  ± 1.30 Moderate 
 
Denying benefit 
Malay 3.93  ± 1.27 Moderate 
Chinese 3.79  ± 1.22 Moderate 
India 4.29  ± 1.45 Moderate 
 
Religious acceptance 
Malay 4.21  ± 1.78 Moderate 
Chinese 4.76  ± 1.45 Moderate 
India 4.54  ± 1.48 Moderate 
 
Ethical acceptance 
Malay 4.34  ± 1.49 Moderate 
Chinese 4.79  ± 1.28 Moderate 
India 4.85  ± 1.45 Moderate 
 




Table 7. One way ANOVA to compare ethical perception of transgenic 
banana across races. 
 
Variable F-value Significant 
Familiarity 4.15 0.016* 
Perceived risks  1.48 0.230 
Denying benefits 3.10 0.046* 
Religious acceptance 3.71 0.025* 
Ethical acceptance 5.19 0.006** 
 




denying benefits (F = 3.10, p < 0.05), religious 
acceptance (F = 3.71, p < 0.05) and ethical acceptance 
across races (F = 5.19, p < 0.01) (Table 7). Post-hoc 
tests confirmed that the Indian respondents accepted 
more of the ethical aspects of transgenic banana 
compared to the Malays and the Chinese accepted more 
of transgenic banana from their religious point of view as 
compared to the Malays. 
 
 
Perception across religion 
 
Respondents from all religion were not very familiar with  
transgenic banana (mean score below the mid-point 
value of 4.0) but accepted the ethical aspects of 
transgenic banana and from their religious point of view 
(mean score above the mid-point value of 4.0) (Table 8). 
Majority of the races except the Hindus perceived 
transgenic banana as risky (mean score above mid-point 
value of 4.0) and were not acknowledging the potential 
benefits of transgenic banana (mean score below mid-
point value, 4.0). ANOVA were significant for perceived 
risks (F = 5.63, p < 0.01), denying benefits (F = 3.48, p < 
0.05) and ethical acceptance across religion (F = 4.54, p 
< 0.01) (Table 9). Post-hoc tests showed that the  Hindus  




Table 8. Ethical perception of transgenic banana across religion. 
 
Variable Mean score ± standard deviation Interpretation 
Familiarity   
Islam 3.28  ± 1.20 Moderate 
Buddha 3.37  ± 1.12 Moderate 
Hindu 2.88  ± 1.15 Low 
Christian 3.07  ± 1.22 Moderate 
 
Perceived risk  
Islam 4.24  ± 1.27 Moderate 
Buddha 4.26  ± 1.17 Moderate 
Hindu 3.78  ± 1.32 Moderate 
Christian 4.76  ± 1.29 Moderate 
 
Denying benefit 
Islam 3.93  ± 1.26 Moderate 
Buddha 3.94  ± 1.00 Moderate 
Hindu 4.38  ± 1.47 Moderate 
Christian 3.62  ± 1.38 Moderate 
 
Religious acceptance 
Islam 4.20  ± 1.78 Moderate 
Buddha 4.77  ± 1.40 Moderate 
Hindu 4.58  ± 1.53 Moderate 
Christian 4.57  ± 1.60 Moderate 
 
Ethical acceptance 
Islam 4.33  ± 1.49 Moderate 
Buddha 4.72  ± 1.27 Moderate 
Hindu 5.05  ± 1.44 High 
Christian 4.41  ± 1.40 Moderate 
 




Table 9. One way ANOVA to compare ethical perception of 
transgenic banana across religion. 
 
Variable F-value Significant 
Familiarity 2.40 0.067 
Perceived risks  5.63 0.001** 
Denying benefits 3.48 0.016* 
Religious acceptance 2.45 0.063 
Ethical acceptance 4.54 0.004** 
 




perceived lower risks of transgenic banana to human and 
the environment and felt that transgenic banana was 
more beneficial to society as compared to the Christians. 
They also highly accepted the ethical aspects of 
transgenic banana compared to the Muslims. 
 
 
Perception across age groups 
 
All groups of respondents irrespective  of  ages  were  not  
very familiar with transgenic banana (mean score below 
the mid-point value of 4.0), rated transgenic banana as 
moderately risky (mean score above the mid-point value of 
4.0) and moderately accepted its ethical aspects as well as 
moderately accepting transgenic banana in accordance with 
their religious perspectives (Table 10). The youth in the age 
range of 26 to 40 years old considered that the potential 
benefits of transgenic banana will be more denied if it is not 
developed (mean score above mid-point value, 4.0) com- 




Table 10. Ethical perception of transgenic banana across age groups. 
 
Variable Mean score ± standard deviation Interpretation 
Familiarity 
18 - 25 years 3.31  ± 1.06 Moderate 
26 - 40 years 3.31  ± 1.28 Moderate 
≥ 41 years 2.79  ± 1.26 Low 
 
Perceived risk 
18 - 25 years 4.17  ± 1.19 Moderate 
26 - 40 years 4.17  ± 1.32 Moderate 
≥ 41 years 4.45  ± 1.51 Moderate 
 
Denying benefit 
18 - 25 years 3.96  ± 1.20 Moderate 
26 - 40 years 4.07  ± 1.36 Moderate 
≥ 41 years 3.77  ± 1.39 Moderate 
 
Religious acceptance 
18 - 25 years 4.39  ± 1.66 Moderate 
26 - 40 years 4.33  ± 1.72 Moderate 
≥ 41 years 4.36  ± 1.72 Moderate 
 
Ethical acceptance 
18 - 25 years 4.51  ± 1.36 Moderate 
26 - 40 years 4.50  ± 1.51 Moderate 
≥ 41 years 4.49  ± 1.64 Moderate 
 




Table 11. One way ANOVA to compare ethical perception of 
transgenic banana across age groups. 
 
Variable F-value Significant 
Familiarity 6.06 0.003** 
Perceived risks  1.52 0.221 
Denying benefits 1.39 0.251 
Religious acceptance 0.06 0.941 
Ethical acceptance 0.02 0.998 
 




pared to the other two age groups (18 to 25 years and ≥ 
41 years). ANOVA was only significant for familiarity 
across age groups and post-hoc test showed that the 
younger groups (18 to 25, and 26 to 40 years) were more 
familiar with transgenic banana compared to the older 
groups (≥ 41 years) (Table 11). 
 
 
Perception across educational level 
 
All respondents irrespective of educational levels profess-
ed they were not very familiar with transgenic banana 
(mean score below mid-point value, 4.0) (Table 12), 
rating transgenic banana as moderately risky, but they 
considered the ethical aspects of transgenic banana as 
moderately acceptable and moderately accepting it by 
their religious perspectives (mean score above mid-point 
value of 4.0) (Table 12). On the other hand, the respon-
dents with only secondary or diploma/pre-university 
levels of education believed that the potential benefits of 
transgenic banana will be more denied if it is not 
developed (mean score above the mid-point value, 4.0) 
compared to the respondents with university level of 
education. However, ANOVA showed no significant diffe- 




Table 12. Ethical perception of transgenic banana across educational level. 
 
Variable Mean score ± standard deviation Interpretation 
Familiarity 
Secondary 3.21  ± 1.24 Moderate 
Diploma/pre-university 3.29  ± 1.15 Moderate 
University 3.18  ± 1.20 Moderate 
 
Perceived risk 
Secondary 4.32  ± 1.27 Moderate 
Diploma/pre-university 4.02  ± 1.26 Moderate 
University 4.28  ± 1.31 Moderate 
 
Denying benefit 
Secondary 4.05  ± 1.26 Moderate 
Diploma/pre-university 4.06  ± 1.18 Moderate 
University 3.91  ± 1.35 Moderate 
 
Religious acceptance 
Secondary 4.26  ± 1.58 Moderate 
Diploma/pre-university 4.19  ± 1.67 Moderate 
University 4.45  ± 1.72 Moderate 
 
Ethical acceptance 
Secondary 4.35  ± 1.54 Moderate 
Diploma/pre-university 4.49  ± 1.32 Moderate 
University 4.54  ± 1.51 Moderate 
 





Table 13. One way ANOVA to compare ethical perception of 
transgenic banana across educational level. 
 
Variable F-value Significant 
Familiarity 0.28 0.758 
Perceived risks  1.68 0.188 
Denying benefits 0.58 0.558 
Religious acceptance 0.96 0.383 
Ethical acceptance 0.44 0.647 
 




rences of ethical perception of transgenic banana across 
educational level (Table 13).   
 
 
Perception across gender 
 
Both category of respondents, male and female were not 
very familiar with transgenic banana (mean score below 
mid-point value of 4.0) and perceived transgenic banana 
as risky to human and to the environment (mean score 
above mid-point value). On the other hand, the respon-
dents from both gender were moderately accepting the 
ethical aspects and from their religious point of views 
(Table 14). The females believed that the potential bene-
fit of transgenic banana will be more denied if it is not 
developed compared to the male respondents. However, 
t-tests were not significant for the ethical perception of 





Overall, the Malaysian stakeholders were cautious  about  




Table 14. Ethical perception of transgenic banana across gender. 
 
Variable Mean score ± standard deviation t-test Significant 
Familiarity 
Male 3.23  ±  1.34 0.126 0.900 
Female 3.21  ±  1.10   
 
Perceived risk 
Male 4.16  ±  1.41 0.720 0.472 
Female 4.25  ±  1.22   
 
Denying benefit 
Male 3.86  ±  1.36 1.347 0.179 
Female 4.03  ±  1.25   
 
Religious acceptance 
Male 4.50  ±  1.66 1.273 0.204 
Female 4.28  ±  1.71   
 
Ethical acceptance 
Male 4.61  ±  1.50 1.232 0.218 
Female 4.43  ±  1.45   
 




transgenic banana. From the results, it becomes 
apparent that all the stakeholders in the Klang Valley 
region including the scientists and policy makers were 
unfamiliar with transgenic banana. This finding is not 
surprising as modern biotechnology has been associated 
with only moderate level of awareness and knowledge 
among the Malaysian public, besides it being considered 
as novel and complex and with no mandatory labeling of 
modern biotechnology products in Malaysia as well as 
limited periodic coverage on modern biotechnology 
issues in the Malaysian general mass-media (Latifah et 
al., 2008). This situation is not unique to Malaysians. The 
public in the United Kingdom were also found to have low 
familiarity with GM foods (Kirk et al., 2002). 
Due to unfamiliarity of transgenic banana, majority of 
stakeholders perceived it as risky to human and to the 
environment. They felt that transgenic banana might 
cause extinction of its original species and possibly can 
cause a major catastrophe to the Malaysian society. They 
were also worried in consuming transgenic banana, and 
were also concerned on its long term harmful effects that 
will manifest after consuming it. Their concern might be 
related to their worriness on the safety of transgenic 
banana for consumption and whether appropriate re-
search has been done to identify all the possible effects. 
Latifah et al. (2010) found that when a GM product was 
perceived as less familiar, the risks associated with it will 
also be less acceptable. On the other hand, if the GM 
product was perceived as more familiar, it will also be 
rated as more beneficial. In this study, the scientists who 
claimed to be more familiar with transgenic banana, 
perceived it as more beneficial compared to the other 
stakeholders’ groups. 
Overall, the Klang Valley respondents acknowledged 
marginal potential benefits of transgenic banana to the 
society (mean score of 3.97, that is, about the mid-point 
value of 4.0). This could be due to the balancing relation-
ship between perceived risks and benefit (Latifah et al., 
2010; Gaskel et al., 2004; Rowe, 2004). As transgenic 
banana was considered as risky, it was perceived as not 
very beneficial to the society too. Even though the 
scientists rated transgenic banana as more beneficial but 
their rating is still considered as moderate and their 
opinion only significantly differed compared to the 
Christian scholars. This scenario could also be related to 
the source of gene inserted into the banana (human 
albumin gene). Major groups of stakeholders considered 
the ethical and religious acceptance of transgenic banana 
as moderate. Moral concern has been negatively asso-
ciated with perceived benefits and positively link with 
risks (Latifah et al., 2010, Gaskel et al., 2000; Sjoberg, 
2004). 
Comparing across stakeholders, the Islamic scholars 
were the only group who claimed transgenic banana as 
unacceptable ethically and from their religious point of 
view. This could again be related to the source of the 
gene transferred to banana (human albumin gene). The 
use of human gene in food seemed sensitive and not 
acceptable to the Muslim scholars. There is a need to 
determine the permissibility status of  the  use  of  human  




gene in food from the perspective of Islamic laws and if 
true, it is not allowed under the Islamic laws; thus, other 
permissible sources of gene should be considered. On 
the opposite end, it is interesting to note that the Indians 
and Hindu followers accepted the ethical aspects of 
transgenic banana the most, perceived the lowest risks 
and the highest benefits compared to other races and 
religions. 
The youth respondents (40 years old and below) were 
found to be more familiar with transgenic banana. This 
could be due to the fact that the younger generations 
were either still studying in universities or just beginning 
their career where they were more likely to be involved in 
information seeking. Lorence and Park (2006) reported 
that younger participants (18 to 29 years) exhibited the 
highest rates in the use of internet. Although, other socio-
demographic variables such as, gender and education 
have been shown to affect people’s risk perception and 
attitude towards science (Connor and Siegrist, 2010; 
Simon, 2010) but in this study, there were no significant 
effect of gender and education on their ethical perception 





Although, the idea of producing an edible vaccine through 
transgenic banana seems to be an ideal alternative for 
cheaper vaccines in Malaysia, the Malaysian public in the 
Klang Valley region were still not ready and have a 
cautious stance. The unfamiliarity of the transgenic bana-
na to them, the moderate level of ethical and religious 
acceptance translated to their perceiving transgenic 
banana as risky and marginally beneficial to society. 
There is a need for a more in-depth study to understand 
the permissibility status of cross species gene transfers 
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